Interestingly, when investigating MAPK signalling in our cell models of NSCLC, we found that H460 βIII‐tubulin suppressed cells expressed higher basal levels of both p‐MEK and p‐ERK, suggesting a possible, as‐yet unexplored, role for βIII‐tubulin in impacting MAPK signalling. The gene discussed is MAP2K7; the disease is non-small cell lung carcinoma.